Janus Henderson Investors US’s Elevance Health ELV Stock Holding History

Janus Henderson Investors US’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$184M	Buy	1,109,792 +189,604	+21%	+$30.2M	0.15%	191
2016 Q4	$132M	Sell	920,188 -107,174	-10%	-$14.4M	0.11%	234
2016 Q3	$129M	Sell	1,027,362 -900,060	-47%	-$116M	0.11%	248
2016 Q2	$253M	Sell	1,927,422 -483,277	-20%	-$66.1M	0.22%	116
2016 Q1	$335M	Sell	2,410,699 -516,775	-18%	-$69.1M	0.29%	76
2015 Q4	$408M	Buy	2,927,474 +159,800	+6%	+$22M	0.35%	62
2015 Q3	$387M	Buy	2,767,674 +492,409	+22%	+$74M	0.35%	65
2015 Q2	$373M	Buy	2,275,265 +22,672	+1%	+$3.62M	0.31%	74
2015 Q1	$348M	Sell	2,252,593 -58,700	-3%	-$8.36M	0.29%	86
2014 Q4	$290M	Buy	2,311,293 +584,891	+34%	+$72.3M	0.25%	101
2014 Q3	$207M	Buy	1,726,402 +29,600	+2%	+$3.4M	0.19%	144
2014 Q2	$183M	Sell	1,696,802 -51,000	-3%	-$5.25M	0.17%	170
2014 Q1	$174M	Buy	1,747,802 +428,200	+32%	+$38.7M	0.16%	169
2013 Q4	$122M	Buy	1,319,602 +978,802	+287%	+$87M	0.11%	228
2013 Q3	$28.5M	Buy	340,800 +327,800	+2,522%	+$28.1M	0.03%	475
2013 Q2	$1.06M	Buy	+13,000	New	+$973K	﹤0.01%	858

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Investors US's ELV Position: Q1 2017 in Review

Janus Henderson Investors US increased its Elevance Health (ELV) stake by 21% in Q1 2017, buying an estimated $30.2M and bringing the position to 1,109,792 shares worth $184M. The position accounts for 0.15% of the portfolio, ranked #191.

Janus Henderson Investors US first reported a position in ELV in Q2 2013 and has held it in 16 quarters since. The position peaked at $408M in Q4 2015. 795 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

Janus Henderson Investors US held 1,109,792 shares of Elevance Health worth $184M as of Q1 2017.
Janus Henderson Investors US bought 189,604 Elevance Health shares in Q1 2017, an estimated $30.2M.
Elevance Health made up 0.15% of Janus Henderson Investors US's portfolio in Q1 2017, its #191 holding.
Janus Henderson Investors US first reported a position in Elevance Health in Q2 2013 and has held it in 16 quarters since.
Janus Henderson Investors US's Elevance Health position peaked at $408M in Q4 2015.
795 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.